Key Metrics
CiteScore 

0.3
H-Index 

5
SJR 

Q2Oncology

Recommended pre-submission checks
Powered by 

Topics Covered on Oncology and Therapy
Oncology and Therapy Journal Specifications
| Overview | |
| Publisher | SPRINGER |
| Language | English |
| Frequency | Semi-annual |
| Article Processing Charges | EUR 4500 | USD 5600 | GBP 4100 |
| Publication Time | 6 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Semi-annual |
| Publication Start Year | 2016 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Publication Time | 6 |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in Oncology and Therapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Oncology and Therapy
Real-World Outcomes Among Medicare Beneficiaries Treated with Bruton Tyrosine KinaseInhibitors for Treatment-Naïve CLL.
- 22 Jun 2026
- Oncology and therapy
Real-World Actionability Analysis of Comprehensive Genomic Profiling Versus Single/Small-Gene Panels.
- 21 Jun 2026
- Oncology and therapy
Beyond the BCG Paradox: Biological Rationale and Clinical Evidence for Combining Intravesical BCG with Immune Checkpoint Inhibitors in High-Risk Non-muscle-Invasive Bladder Cancer.
- 11 Jun 2026
- Oncology and therapy
Publisher Correction: Perioperative Treatment Patterns for Muscle-Invasive Bladder Cancer Patients Undergoing Radical Cystectomy in the Adjuvant Immunotherapy Era: A Retrospective Analysis of US Community Oncology Practice.
- 9 Jun 2026
- Oncology and therapy
Machine Learning-Guided Survival Prediction and Treatment Sequencing in Advanced Soft Tissue Sarcoma Beyond Second-Line Therapy: A Retrospective Cohort Study.
- 5 Jun 2026
- Oncology and therapy
Association of Variants in Candidate Pharmacogenes with Response to Mercaptopurine and Methotrexate in Pediatric Acute Lymphoblastic Leukemia: A Single-Center Experience from Croatia.
- 1 Jun 2026
- Oncology and therapy
Real-World Outcomes Among Medicare Beneficiaries Treated with Bruton Tyrosine KinaseInhibitors for Treatment-Naïve CLL.
- 22 Jun 2026
- Oncology and therapy
Real-World Actionability Analysis of Comprehensive Genomic Profiling Versus Single/Small-Gene Panels.
- 21 Jun 2026
- Oncology and therapy
Beyond the BCG Paradox: Biological Rationale and Clinical Evidence for Combining Intravesical BCG with Immune Checkpoint Inhibitors in High-Risk Non-muscle-Invasive Bladder Cancer.
- 11 Jun 2026
- Oncology and therapy
Publisher Correction: Perioperative Treatment Patterns for Muscle-Invasive Bladder Cancer Patients Undergoing Radical Cystectomy in the Adjuvant Immunotherapy Era: A Retrospective Analysis of US Community Oncology Practice.
- 9 Jun 2026
- Oncology and therapy
Machine Learning-Guided Survival Prediction and Treatment Sequencing in Advanced Soft Tissue Sarcoma Beyond Second-Line Therapy: A Retrospective Cohort Study.
- 5 Jun 2026
- Oncology and therapy
Association of Variants in Candidate Pharmacogenes with Response to Mercaptopurine and Methotrexate in Pediatric Acute Lymphoblastic Leukemia: A Single-Center Experience from Croatia.
- 1 Jun 2026
- Oncology and therapy